Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to increase endogenous growth hormone production. By promoting natural, pulsatile release of growth hormone, it supports lean body composition, tissue repair, recovery, and overall metabolic function. Its mechanism of action offers a physiologic approach to growth hormone optimization without significantly affecting other endocrine pathways.

Clinicians often integrate Sermorelin into comprehensive wellness, anti-aging, or performance protocols to enhance energy, body composition, and tissue regeneration. Its safety profile and predictable action make it a versatile option in physician-supervised peptide therapy. Administration should be individualized, closely monitored, and conducted in compliance with regulatory and clinical guidelines.